SHBG may inhibit the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway, which plays a role in the development of both local and systemic insulin resistance (IR) [23]. The gene discussed is AKT1; the disease is Insulin resistance.